What does CUSIP 76243J105 represent in this 13F holders report?

CUSIP 76243J105 is the security identifier for RYTM - RHYTHM PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held RYTM - RHYTHM PHARMACEUTICALS, INC. - Common Stock in Q3 2022?

99 institutional investors reported RYTM - RHYTHM PHARMACEUTICALS, INC. - Common Stock for Q3 2022. Use the holders table for investor-level position and value details.

RHYTHM PHARMACEUTICALS, INC. - Common Stock (RYTM)

CUSIP: 76243J105

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Equity / Common Stock
Shares outstanding: 68,385,438
Total 13F shares: 59,549,165
Share change: +13,527,358
Total reported value: $1,446,896,472
Put/Call ratio: 44%
Price per share: $24.50
Number of holders: 99
Value change: +$426,232,319
Number of buys: 71
Number of sells: 39

Quarterly Holders Quick Answers

What is CUSIP 76243J105?
CUSIP 76243J105 identifies RYTM - RHYTHM PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2022
Previous quarter: Q2 2022

Recent filing periods for CUSIP 76243J105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RYTM - RHYTHM PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PRIMECAP MANAGEMENT CO/CA/	13F	Company	9.3%	6,364,094	$26,411,000	—	30 Jun 2022	13F
NEA Management Company, LLC	13F	Company	7.2%	4,912,306	$20,386,000	—	30 Jun 2022	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	7.1%	4,871,067	$20,215,000	—	30 Jun 2022	13F
FEDERATED HERMES, INC.	13F	Company	6.4%	4,395,600	$18,242,000	—	30 Jun 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	6%	4,125,062	$17,119,000	—	30 Jun 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	4.6%	3,160,386	$13,116,000	—	30 Jun 2022	13F
VANGUARD GROUP INC	13F	Company	3.1%	2,149,726	$8,922,000	—	30 Jun 2022	13F
JANUS HENDERSON GROUP PLC	13F	Company	3%	2,080,077	$8,632,000	—	30 Jun 2022	13F
FRANKLIN RESOURCES INC	13F	Company	2.6%	1,779,430	$7,385,000	—	30 Jun 2022	13F
ALKEON CAPITAL MANAGEMENT LLC	13F	Company	2.2%	1,500,000	$6,225,000	—	30 Jun 2022	13F
Rock Springs Capital Management LP	13F	Company	2.1%	1,403,298	$5,824,000	—	30 Jun 2022	13F
BlackRock Finance, Inc.	13F	Company	1.7%	1,177,575	$4,887,000	—	30 Jun 2022	13F
MPM ASSET MANAGEMENT LLC	13F	Company	1.3%	909,258	$3,773,000	—	30 Jun 2022	13F
Assenagon Asset Management S.A.	13F	Company	1%	689,720	$2,862,000	—	30 Jun 2022	13F
FMR LLC	13F	Company	0.81%	556,994	$2,312,000	—	30 Jun 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.72%	489,121	$2,030,000	—	30 Jun 2022	13F
MORGAN STANLEY	13F	Company	0.63%	430,735	$1,788,000	—	30 Jun 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.58%	399,794	$1,659,000	—	30 Jun 2022	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.55%	378,714	$1,572,000	—	30 Jun 2022	13F
Opaleye Management Inc.	13F	Company	0.53%	362,000	$1,502,000	—	30 Jun 2022	13F
Samsara BioCapital, LLC	13F	Company	0.5%	345,293	$1,433,000	—	30 Jun 2022	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.43%	291,005	$1,208,000	—	30 Jun 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.37%	253,241	$1,050,000	—	30 Jun 2022	13F
STATE STREET CORP	13F	Company	0.37%	251,059	$1,042,000	—	30 Jun 2022	13F
Ergoteles LLC	13F	Company	0.31%	212,800	$883,000	—	30 Jun 2022	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.3%	207,701	$862,000	—	30 Jun 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.25%	172,730	$717,000	—	30 Jun 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.25%	168,058	$698,000	—	30 Jun 2022	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.23%	159,000	$660,000	—	30 Jun 2022	13F
CAXTON ASSOCIATES LP	13F	Company	0.22%	151,213	$628,000	—	30 Jun 2022	13F
Linda Shapiro Manning	3/4/5	Chief Medical Officer	— mixed-class rows	87,500 mixed-class rows	$563,250	—	09 Feb 2022	3/4/5
TUDOR INVESTMENT CORP ET AL	13F	Company	0.18%	125,416	$520,000	—	30 Jun 2022	13F
NORTHERN TRUST CORP	13F	Company	0.16%	111,249	$462,000	—	30 Jun 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.14%	98,091	$407,000	—	30 Jun 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.13%	85,565	$355,000	—	30 Jun 2022	13F
Swiss National Bank	13F	Company	0.12%	83,300	$346,000	—	30 Jun 2022	13F
SG Americas Securities, LLC	13F	Company	0.12%	80,064	$332,000	—	30 Jun 2022	13F
Bell & Brown Wealth Advisors, LLC	13F	Company	0.1%	70,400	$293,000	—	30 Jun 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.09%	64,261	$267,000	—	30 Jun 2022	13F
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	13F	Company	0.08%	57,218	$237,000	—	30 Jun 2022	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.08%	54,823	$227,515	—	30 Jun 2022	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.08%	52,519	$218,000	—	30 Jun 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.07%	49,005	$203,000	—	30 Jun 2022	13F
Squarepoint Ops LLC	13F	Company	0.06%	44,164	$183,000	—	30 Jun 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.06%	41,205	$171,000	—	30 Jun 2022	13F
Chicago Partners Investment Group LLC	13F	Company	0.02%	12,821	$162,000	—	30 Jun 2022	13F
CORNERCAP INVESTMENT COUNSEL INC	13F	Company	0.05%	36,663	$152,000	—	30 Jun 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.05%	36,492	$151,000	—	30 Jun 2022	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.05%	31,946	$133,000	—	30 Jun 2022	13F
BAILARD, INC.	13F	Company	0.04%	29,500	$122,000	—	30 Jun 2022	13F

Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - Common Stock (RYTM) as of Q3 2022

As of 30 Sep 2022, RHYTHM PHARMACEUTICALS, INC. - Common Stock (RYTM) was held by 99 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 59,549,165 shares. The largest 10 holders included PRIMECAP MANAGEMENT CO/CA/, FEDERATED HERMES, INC., BAKER BROS. ADVISORS LP, RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, GOLDMAN SACHS GROUP INC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, and Frazier Life Sciences Management, L.P.. This page lists 99 institutional shareholders reporting positions in this security for the Q3 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

Q3 2022 holders

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 Value $	Q3 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.